Chemical industry in Norway

NOK 260m project to replace a furnace and off-gas equipment; installation starts Q1 2027; second furnace stays operational; aims to cut emissions and enable more biocarbon use.

€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.

SMART‑N technology under an EPF contract with modular off‑site fabrication, 10–100% operating range with staged hydrogen rollout and downstream conversion to nitric acid and fertilizers.

Follows Norway's finding that domestic producers were under‑allocated versus EU peers; five plants to receive EU‑aligned allocations for 2026–2030.

CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.

CHMP recommends approval after KEYNOTE-B15 showed event-free survival, overall survival and pathologic complete response gains; European Commission decision expected Q4 2026.

First complete cross-border CCS value chain; captures 800,000 tCO₂/yr from ammonia, shipped to Norway for permanent seabed storage, ~12 Mt over 15 years.

From 2029 decommissioning spend will exceed capital; approving Jackdaw and Rosebank and restoring fiscal stability could retain ~£11bn planned investment and avoid a ~£13bn fiscal hit by 2035.

Regional platform mobilises 14 organisations to coordinate offshore wind, LNG/bioLNG, hydrogen, CCS, SMRs and infrastructure protection across the Baltic Sea region.

Revenue up 15% to RM152.4bn; PAT RM27.2bn; CAPEX RM41.4bn and full ownership of PRefChem expected in 2H 2026 amid West Asia conflict-driven volatility.